A detailed history of Arlington Trust CO LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Arlington Trust CO LLC holds 5,050 shares of ABBV stock, worth $918,797. This represents 0.24% of its overall portfolio holdings.

Number of Shares
5,050
Previous 5,200 2.88%
Holding current value
$918,797
Previous $805,000 14.16%
% of portfolio
0.24%
Previous 0.23%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

SELL
$159.82 - $182.1 $23,973 - $27,315
-150 Reduced 2.88%
5,050 $919,000
Q4 2023

Jan 24, 2024

BUY
$137.6 - $154.97 $715,520 - $805,844
5,200 New
5,200 $805,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $322B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Arlington Trust CO LLC Portfolio

Follow Arlington Trust CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arlington Trust CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arlington Trust CO LLC with notifications on news.